|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,392.00 GBX | -1.52% |
|
-5.41% | -0.73% |
| 06-02 | ASTRAZENECA : Buy rating from JP Morgan | ZD |
| 06-02 | UK's FTSE 100 closes around flat as staples, healthcare losses eclipse energy gains | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Biopharmaceuticals | 26.62B | 37.42B | 44.35B | 45.81B | 54.07B | |||||
Total Assets | 66.73B | 105B | 96.48B | 101B | 104B | |||||
Interest Expense | -738M | -776M | -917M | -1.22B | -1.4B | |||||
Income Tax Expense | 772M | -380M | -792M | 938M | 1.65B | |||||
CAPEX | -2.61B | -2.2B | -2.57B | -1.36B | -1.92B | |||||
EBT | 3.94B | -201M | 2.51B | 6.91B | 8.72B | |||||
Gross Profit | 21.32B | 24.98B | 31.96B | 37.54B | 43.87B | |||||
D&A | 2.83B | 4.04B | 5.18B | 4.85B | 4.98B | |||||
Operating Income | 5.16B | 1.06B | 3.76B | 8.19B | 10B | |||||
Net Income | 3.2B | 112M | 3.29B | 5.96B | 7.04B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 8.96B | 12.05B | 17.28B | 18.12B | 21.81B | |||||
Total Assets | 5.5B | 6.06B | 6.04B | 6.11B | 7.47B | |||||
CAPEX | -116M | -94M | - | - | - | |||||
EBT | 745M | 931M | 660M | 1.15B | 967M | |||||
Operating Income | 742M | 943M | 646M | 1.15B | 976M | |||||
China | 5.34B | 6B | 5.74B | 5.87B | 6.42B | |||||
United Kingdom | 1.74B | 3.24B | 3.12B | 3.37B | 4.74B | |||||
Total Assets | 17.85B | 16.62B | 16.79B | 19.62B | 20.14B | |||||
CAPEX | -1.61B | -810M | - | - | - | |||||
EBT | 518M | -1.48B | 272M | -577M | 1.35B | |||||
Operating Income | 824M | -950M | 1.12B | 665M | 2.68B | |||||
Other Rest of Europe | 1.39B | 1.95B | 2.71B | 3.11B | 3.66B | |||||
Japan | 2.57B | 3.4B | 3.99B | 3.64B | 3.45B | |||||
Germany | 937M | 1.49B | 1.9B | 2.1B | 2.52B | |||||
Other Asia, Africa & Australasia | 1.53B | 2.38B | 2.41B | 2.04B | 2.33B | |||||
Sweden | 1.03B | 2.32B | 1.72B | 1.7B | 2.29B | |||||
Total Assets | 23.64B | 34.3B | 32.99B | 34.75B | 38.54B | |||||
CAPEX | -286M | -10.81B | - | - | - | |||||
EBT | 297M | -2.4B | -1.14B | 1.33B | 318M | |||||
Operating Income | 758M | -1.94B | -954M | 1.5B | 423M | |||||
Total Assets | 19.74B | 48.38B | 40.67B | 40.64B | 37.88B | |||||
CAPEX | -505M | -26.53B | - | - | - | |||||
EBT | 2.36B | 2.68B | 2.71B | 5B | 6.06B | |||||
Operating Income | 2.84B | 3B | 2.94B | 4.88B | 5.92B | |||||
Other Americas | 761M | 1.2B | 1.18B | 1.68B | 2.25B | |||||
France | 653M | 915M | 1.11B | 1.15B | 1.28B | |||||
Spain | 398M | 578M | 738M | 847M | 994M | |||||
Italy | 431M | 577M | 735M | 813M | 949M | |||||
Canada | 596M | 772M | 1.17B | 967M | 937M | |||||
Australia | 282M | 547M | 571M | 390M | 439M | |||||
Intra-Group Eliminations | - | - | - | - | - | |||||
Belgium | - | - | - | - | - | |||||
Corporate | - | - | - | - | - |
- Stock Market
- Equities
- AZN Stock
- Financials AstraZeneca PLC
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition